MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Predictive Accuracy of Baseline DaT-SPECT for Freezing of Gait at 5, 7, and 10-year Follow up in The PPMI Cohort

    J. Li, R. Rajmohan, J. Ruiz Tejeda, N. Phielipp (Irvine, USA)

    Objective: To see if segmentation models of baseline DaT-SPECT striatal binding ratios (SBR) will predict freezing of gait (FoG) in Parkinson’s Disease over a 5,…
  • 2024 International Congress

    Enviromental Risk Factors for Parkinson’s Disease in the Nigeria Parkinson’s Disease Research Network

    N. Obianozie, O. Ojo, 0. Agabi, N. Okubadejo, N. Research Network (Abuja, Nigeria)

    Objective: To determine the risk factors associated with Parkinson’s disease (PD) development in the Nigerian PD Research (NPDR) cohort Background: PD is widely believed to…
  • 2024 International Congress

    Dynamic video-assessment of axial postural abnormalities in parkinsonism: feasibility and pilot analysis

    C. Geroin, C. Artusi, S. Camozzi, G. Imbalzano, S. Aldegheri, L. Lopiano, N. Bombieri, M. Tinazzi (Verona, Italy)

    Objective: To evaluate changes in the degree of axial postural abnormalities (APAs) using the AutoPosturePD software during standing and walking under single/dual-task conditions. Background: We…
  • 2024 International Congress

    Lingual-Masticatory Myorhythmia and Palatal Tremor as a Presentation of Anti-IgLON5 Disease

    RY. Wu, CC. Hsieh, YT. Sun, TL. Lee (Tainan, Taiwan)

    Objective: Anti-immunoglobulin-like cell adhesion molecule-5 (anti-IgLON5) disease may manifest with spectrum of various neurological presentations and movement disorders, including prominent sleep movement disorders, bulbar symptoms,…
  • 2024 International Congress

    Initiating a Hybrid-Modality International Movement Disorders Fellowship: A Collaborative Effort Among Latin American Countries

    P. Salles, S. Peña, S. Silva, R. Jauregui, P. Saffie, P. Chaná-Cuevas (Santiago de Chile, Chile)

    Objective: To describe a hibrid modality with high-quality, well-structured and overseeded education program. Background: In the field of movement disorders, specialized centers have emerged as…
  • 2024 International Congress

    Utility of Serum α-synuclein Seed Amplification Assay as a Parkinson’s Disease Biomarker

    S. Mosovsky, A. Okuzumi, C. Adler, T. Beach, T. Foroud, G. Serrano, J. Eberling, L. Oliveira, T. Hatano, N. Hattori, B. Mollenhauer, L. Chahine (Pittsburgh, USA)

    Objective: To determine the sensitivity and specificity of serum α-synuclein seed amplification assay (SAA) for Parkinson’s disease (PD) diagnosis in the Systemic Synuclein Sampling Study…
  • 2024 International Congress

    Movement Disorders in the Emergency:New Insights

    A. Banik, D. Manna, S. Pal, A. Chakravarty, I. Dutta, A. Chattopadhyay, S. Banerjee (kolkata, India)

    Objective: The study objective was to assess the clinico-epidemiological aspects of patients attending the Emergency with movement disorder as the primary symptom. Background: Available literature…
  • 2024 International Congress

    Wilson’s Disease About A Complex Case

    A. Ouedraogo, V. Ouedraogo, A. Savadogo (Bobo-Dioulasso, Burkina Faso)

    Objective: We report the case of a patient who experienced diagnostic wavering. Background: Wilson disease is a rare disease. Cases in Africa is even rarer.…
  • 2024 International Congress

    A Phase 2 Study of ATH434 a Novel Inhibitor of α-Synuclein Aggregation for the Treatment of Multiple System Atrophy

    D. Stamler, C. Wong, P. Trujillo, M. Bradbury, C. Lucas, D. Claassen (Newark, USA)

    Objective: Describe baseline fluid and neuroimaging biomarker data of an early MSA study population Background: MSA is a rapidly progressive neurodegenerative disorder characterized by aggregated…
  • 2024 International Congress

    Seed Amplification Assay for the differentiation of αSyn seed subtypes

    C. Farris, S. Weber, Y. Ma, H. Nguyen, S. Rosete-Gonzalez, A. Siderowf, U. Kang, B. Mollenhauer, L. Concha-Marambio (san diego, USA)

    Objective: To identify soluble αSyn-seed types present in brain homogenate (BH) and CSF using αSyn seed amplification assay (synSAA) Background: Lewy bodies and neurites are…
  • « Previous Page
  • 1
  • …
  • 124
  • 125
  • 126
  • 127
  • 128
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley